CDC25C and diffuse large B-cell lymphoma: Inhibition of CHK kinases effectively resulted in inhibition of the phosphorylation of the downstream target CDC25c, and increased the phosphorylation of the DNA damage marker γH2AX both in DLBCL cell lines and primary cells.